Back to School: How biopharma can reboot drug development. Access exclusive analysis here

MediciNova pulls follow-on

MediciNova (MNOV; Osaka:4875) withdrew a proposed follow-on offering of up to 6 million shares. MNOV,

Read the full 159 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE